Stocks surged around the world and bonds tumbled after a large-scale coronavirus vaccine study delivered the most-promising results in the battle against the worst pandemic in a century.
More than 85% of S&P 500 companies climbed Monday as the gauge jumped to a record on news that the COVID-19 shot being developed by Pfizer Inc. and BioNTech prevented more than 90% of infections. The enthusiasm also drove the Dow Jones Industrial Average to an all-time high and sparked a rally in small caps.
At 11:10 a.m. New York Time, the S&P 500 was up 2.57% at 3,599.53. The Dow Jones Industrial Average was up 3.76%, or 1,065.95 points, at 29,389.35.
Shares that have been hit hard by the economic toll of lockdowns such as travel stocks and movie theaters jumped, with Carnival Corp. and Cinemark Holdings Inc. surging more than 35%. Stay-at-home companies Zoom Video Communications Inc. and Peloton Interactive Inc. plunged at least 16% on hopes that a return to normal is on the horizon. Online giant Amazon.com Inc. retreated.
A credit derivatives index that measures the perceived risk of high yield dropped by the most in seven months, with junk-rated companies hitting the market in droves to take advantage of a plunge in borrowing costs. Oil soared, while gold, the Japanese yen and the Swiss franc slumped.
Investors pulled out of haven assets and poured cash into markets that are closely tied to economic growth, with a gauge of global stocks also hitting a record high. President-elect Joe Biden Monday announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to develop a dramatically different approach than President Donald Trump’s to contain the pandemic.
Anthony Fauci, the top infectious disease expert in the U.S., said the vaccine being developed by Pfizer will have a “major impact” on everything we do with regards to the coronavirus going forward.
“The bull market has a ton of ammunition to keep going,” said Chris Larkin, managing director of trading and investing product at ETrade Financial. “With more certainty around the election, a strong quarter of earnings across many sectors, and extremely positive news on the vaccine front, there is little to hold us back.”
Elsewhere, the Australian dollar-yen cross -- a commonly watched risk barometer -- surged by most since June. The Turkish lira soared after the weekend resignation of the country’s economy czar and the dismissal of the central bank chief.
A $141M judgment and a federal asset freeze collide over one shrinking pool
The firm's CFO and EVP of Wealth Management Solutions are the latest executives to exit the broker-dealer.
Clients are saying they would consider switching advisors if another professional offered estate planning services, according to a new Trust & Will survey.
CEO Laurel Taylor says the fintech's composable AI stack helps workers optimize dollars across Trump Accounts, 529s, 401(k)s, and other employee benefits.
The bank has swiped three private banking veterans from BNY as the city climbs the ranks of America's fastest-growing wealth hubs.
Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income
Direct indexing is on pace to outgrow ETFs and mutual funds. Northern Trust's Ken Lassner explains why the advisors who get it wish they had started sooner.
